Female Reproductive Factors and Risk of Mild Cognitive Impairment and Dementia: The HUNT Study - 21/11/24

Doi : 10.14283/jpad.2024.46 
Yehani Wedatilake 1, 2, 3, , C. Myrstad 1, 4, S.E. Tom 5, 6, B.H. Strand 1, 3, 7, S. Bergh 1, 2, G. Selbæk 1, 3, 8
1 Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway 
2 Research Centre for Age-related Functional Decline and Diseases, Innlandet Hospital Trust, Ottestad, Norway 
3 Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway 
4 Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway 
5 Department of Neurology, Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA 
6 Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA 
7 Division for Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway 
8 Faculty of Medicine, University of Oslo, Oslo, Norway 

a drentz@bwh.harvard.edu drentz@bwh.harvard.edu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

More women are living with dementia than men worldwide and there is a need to investigate causes for this female preponderance. While reproductive factors have been investigated as risk factors, the results are conflicting. We aim to clarify this using a large cohort with a long observation time, adjusting for multiple health and lifestyle variables and encompassing a wider range of cognitive impairment.

Objective

To study the association between menopause age, menarche age and risk of and risk of mild cognitive impairment (MCI) and dementia.

Setting

The Trøndelag Health study (HUNT), a longitudinal population health study in Norway (1984–2019).

Participants

Women who were ≥70 years in 2017–2019 were assessed for cognitive impairment.

Measurements

Data on menopause age and menarche age were obtained from questionnaires. Diagnosis of MCI or dementia was set using a standardised procedure by a diagnostic group of nine physicians. Multinomial logistic regression was used to study the association between menopause age, menarche age and risk of MCI and dementia with adjustment for birth year, education, smoking, ApoE4, number of children, diabetes, body mass index, alcohol use and physical inactivity.

Results

We evaluated 5314 women where 900 (16.9%) had dementia, and 1747 (32.8%) had MCI. Multiple adjusted relative risk ratio (RRR) and 95% confidence intervals (CI) for dementia were: 0.96(95%CI 0.95–0.98) (p<0.001) for menopause age, 0.97(95%CI 0.94–0.99) (p=0.007) for natural menopause age (excluding hysterectomy and/or oophorectomy<55 years) and 0.97(95%CI 0.95–0.99) (p<0.001) for reproductive span (menopause age minus menarche age). Menopause age <45years was associated with a 56% higher risk compared to mean menopause age 50 years. We found no significant associations between menarche age and dementia and no associations with MCI.

Conclusions

Older menopause age and longer reproductive span corresponding to longer oestrogen exposure were associated with a lower dementia risk. Future studies should explore therapeutical options to offset this risk in women.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Dementia, Alzheimer’s disease, menopause, menarche, reproductive


Mappa


© 2024  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 11 - N° 4

P. 1063-1072 - Agosto 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Prediction of Alzheimer’s Disease Based on 3D Genome Selected circRNA
  • R. Chi, K. Li, K. Su, L. Liu, M. Feng, X. Zhang, J. Wang, X. Li, Guang He, Yi Shi
| Articolo seguente Articolo seguente
  • Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects
  • G.M. Giuffrè, Davide Quaranta, M.G. Vita, E.M. Costantini, S. Citro, C. Carrozza, G. De Ninno, P. Calabresi, C. Marra

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.